Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PBYI	PUMA BIOTECHNOLOGY INC	$452.71M	20.90%	13.30%	24.27%	46.50%	0.39	2.91	74.80%	11.60%	15.00%
ICCC	IMMUCELL CORP	$99.06M	-1.90%	-1.20%	-1.30%	-1.10%	0.51	4.82	42.60%	-1.80%	-1.75%
CORT	CORCEPT THERAPEUTICS INC	$12.09B	8.30%	6.40%	0.74%	0.90%	0.26	2.86	98.30%	6.50%	0.65%
PLX	PROTALIX BIOTHERAPEUTICS INC	$195.79M	28.10%	17.80%	27.76%	44.50%	0.52	3.15	70.00%	20.10%	27.24%
PGEN	PRECIGEN INC	$2.46B	-1,063.90%	-211.90%	-104.99%	-77.10%	2.91	4.58	90.70%	-392.80%	-172.64%
ONC	BEONE MEDICINES LTD	$40.89B	14.20%	7.80%	14.29%	27.40%	0.77	3.41	88.90%	10.70%	16.45%
FENC	FENNEC PHARMACEUTICALS INC	$443.94M	-54.80%	-14.20%	-10.89%	-23.20%	0.91	6.98	92.20%	-16.40%	-13.28%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$3.30B	15.10%	6.50%	13.15%	12.00%	1.22	2.92	91.10%	6.10%	9.30%
JAZZ	JAZZ PHARMACEUTICALS PLC	$16.10B	21.40%	8.20%	10.15%	13.40%	1.31	1.78	88.40%	20.40%	19.53%
FBIO	FORTRESS BIOTECH INC	$86.70M	152.90%	54.00%	56.33%	216.20%	0.95	2.86	66.20%	180.20%	215.81%
HALO	HALOZYME THERAPEUTICS INC	$11.65B	180.60%	16.50%	27.03%	24.60%	16.96	2.71	82.40%	24.90%	36.28%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.30B	20.10%	14.10%	22.36%	52.00%	0.37	3.48	75.40%	18.90%	26.53%
PTCT	PTC THERAPEUTICS INC	$6.15B	N/A	-1.30%	4.77%	10.30%	-20.66	3.39	93.00%	-3.80%	11.72%
VCYT	VERACYTE INC	$3.73B	8.60%	8.00%	8.15%	49.40%	0.07	9.16	71.70%	20.40%	20.65%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.64B	N/A	-77.60%	-87.65%	-34.50%	-2.23	2.32	97.80%	-40.90%	-32.52%
REGN	REGENERON PHARMACEUTICALS INC	$82.06B	13.80%	10.60%	14.42%	15.10%	0.32	3.34	84.90%	27.90%	33.61%
PTGX	PROTAGONIST THERAPEUTICS INC	$9.60B	12.00%	11.20%	9.94%	17.10%	0.05	21.71	100.00%	29.40%	29.91%
EXEL	EXELIXIS INC	$12.72B	42.50%	32.00%	48.56%	49.90%	0.35	3.46	96.50%	35.30%	42.51%
RPRX	ROYALTY PHARMA PLC	$33.23B	8.30%	4.10%	6.13%	4.50%	1.03	2.80	100.00%	32.10%	46.37%
LQDA	LIQUIDIA CORP	$7.83B	46.80%	7.10%	20.74%	26.40%	2.70	2.22	91.80%	7.70%	18.13%
VCEL	VERICEL CORP	$2.27B	6.90%	5.00%	5.71%	6.20%	0.36	5.04	74.60%	7.90%	8.40%
BMRN	BIOMARIN PHARMACEUTICAL INC	$13.46B	1.20%	0.80%	2.31%	3.70%	0.85	2.39	76.10%	2.10%	6.83%
ZVRA	ZEVRA THERAPEUTICS INC	$673.41M	32.80%	20.50%	29.52%	42.70%	0.39	5.17	95.50%	42.80%	55.12%
ABUS	ARBUTUS BIOPHARMA CORP	$922.50M	129.30%	112.20%	59.11%	137.60%	0.07	54.26	100.00%	84.00%	84.00%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$6.07B	13.70%	10.10%	15.76%	24.30%	0.37	3.90	89.80%	9.60%	13.59%
ACAD	ACADIA PHARMACEUTICALS INC	$5.07B	32.40%	24.40%	8.79%	13.60%	0.33	3.39	91.10%	33.40%	10.66%
FTRE	FORTREA HOLDINGS INC	$1.86B	-15.50%	-3.10%	0.37%	0.50%	4.18	0.96	19.30%	-3.20%	0.24%
PRLD	PRELUDE THERAPEUTICS INC	$423.71M	-118.20%	-66.10%	-99.84%	-117.90%	0.99	2.03	100.00%	-465.30%	-465.30%
ORMP	ORAMED PHARMACEUTICALS INC	$176.79M	73.00%	64.20%	32.47%	50.70%	0.16	4.98	N/A	N/A	N/A
RLYB	RALLYBIO CORP	$86.99M	68.60%	64.50%	49.61%	272.20%	0.04	27.27	100.00%	7,051.20%	7,256.19%
CUE	CUE BIOPHARMA INC	$114.25M	-98.30%	-53.70%	-80.25%	-306.00%	0.43	3.57	100.00%	-59.60%	-57.58%
ASND	ASCENDIS PHARMA A	$15.81B	-5,435.60%	35.80%	7.06%	7.60%	3.11	1.00	89.00%	57.30%	7.15%
ARGX	ARGENX SE	$54.08B	23.60%	19.90%	20.69%	41.10%	0.19	5.12	N/A	N/A	N/A
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.53B	-426.30%	-4.40%	4.99%	3.70%	-43.32	1.45	86.60%	-5.10%	3.31%
AUPH	AURINIA PHARMACEUTICALS INC	$2.04B	59.00%	44.90%	23.75%	28.20%	0.29	5.42	90.40%	100.80%	52.80%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.51B	-35.40%	-12.20%	-9.52%	-10.20%	1.21	4.05	34.90%	-37.10%	-25.79%
INSM	INSMED INC	$28.95B	-111.30%	-39.80%	-47.35%	-43.80%	1.78	3.72	83.50%	-76.90%	-69.25%
INCY	INCYTE CORP	$24.54B	29.60%	22.60%	30.02%	87.80%	0.24	4.59	92.60%	27.70%	33.85%
ACIU	AC IMMUNE SA	$258.43M	-99.20%	-28.10%	-85.61%	299.80%	3.28	0.93	100.00%	-246.50%	-245.27%
URGN	UROGEN PHARMA LTD	$2.30B	N/A	-43.80%	-42.95%	-34.70%	-2.91	3.80	90.80%	-51.70%	-43.39%
GMAB	GENMAB A	$19.24B	13.60%	7.00%	11.70%	26.80%	1.10	2.46	93.00%	19.10%	32.22%
NVO	NOVO NORDISK A S	$209.24B	59.10%	21.10%	41.80%	49.50%	1.69	0.87	80.60%	35.30%	45.15%
FHTX	FOGHORN THERAPEUTICS INC	$391.35M	N/A	-31.20%	-42.26%	-68.00%	-3.51	3.36	100.00%	-175.80%	-175.78%
ADAG	ADAGENE INC	$184.33M	-41.00%	-21.00%	-32.86%	113.30%	0.75	3.07	100.00%	-229.60%	-227.41%
SLN	SILENCE THERAPEUTICS PLC	$694.78M	N/A	-48.00%	-63.98%	-103.30%	-1.77	7.42	85.90%	-9,748.50%	-9,748.13%
VIR	VIR BIOTECHNOLOGY INC	$1.51B	-30.00%	-23.60%	-22.44%	-31.30%	0.24	6.04	100.00%	-83.00%	-82.87%
SEPN	SEPTERNA INC	$2.23B	-6.30%	-4.10%	-4.70%	-6.10%	0.47	5.00	100.00%	-24.50%	-23.17%
OABI	OMNIAB INC	$491.42M	-16.60%	-14.80%	-16.53%	-64.50%	0.12	4.80	98.30%	-115.10%	-118.86%
SRZN	SURROZEN INC	$294.43M	N/A	-309.60%	-311.58%	-3,438.20%	-1.53	12.14	100.00%	-2,885.30%	-2,885.33%
STTK	SHATTUCK LABS INC	$550.57M	-60.70%	-55.70%	-50.96%	-188.80%	0.07	22.07	100.00%	-4,987.40%	-4,987.40%
XNCR	XENCOR INC	$1.64B	-28.70%	-20.40%	-20.80%	-15.60%	0.44	6.39	100.00%	-155.60%	-127.44%
VRTX	VERTEX PHARMACEUTICALS INC	$134.25B	23.30%	16.90%	22.49%	31.00%	0.35	3.19	86.00%	35.00%	41.96%
ALNY	ALNYLAM PHARMACEUTICALS INC	$29.60B	93.60%	15.80%	27.79%	22.30%	3.11	3.06	79.70%	16.80%	23.41%
MDGL	MADRIGAL PHARMACEUTICALS INC	$12.37B	-56.60%	-25.50%	-33.73%	-29.30%	1.38	3.21	91.50%	-25.30%	-22.87%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$2.94B	-40.50%	-31.60%	-36.33%	-73.20%	0.24	4.35	48.40%	-89.10%	-90.40%
OMER	OMEROS CORP	$984.30M	-54.40%	34.50%	39.48%	16.70%	-5.52	3.03	94.10%	871.00%	904.87%
HCWB	HCW BIOLOGICS INC	$3.56M	-1,138.00%	-68.20%	-17.38%	-16.20%	3.75	0.09	100.00%	-277.00%	-19.61%
ANAB	ANAPTYSBIO INC	$1.68B	N/A	-7.80%	-9.25%	-5.80%	24.86	7.58	100.00%	-11.50%	-11.46%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.66B	N/A	-44.40%	-63.77%	-35.30%	-5.20	1.73	83.10%	-81.70%	-81.18%
LEGN	LEGEND BIOTECH CORP	$4.05B	-24.90%	-14.90%	-19.75%	-31.30%	0.65	2.13	55.00%	-22.00%	-18.86%
RYTM	RHYTHM PHARMACEUTICALS INC	$7.77B	-163.70%	-45.00%	-59.23%	-62.60%	2.14	3.45	89.00%	-87.60%	-77.44%
SCTX	SCRIBE THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.65	0.66	N/A	N/A	N/A
TARS	TARSUS PHARMACEUTICALS INC	$3.05B	-13.50%	-8.10%	-7.02%	-8.90%	0.76	3.20	93.30%	-7.70%	-5.04%
RIGL	RIGEL PHARMACEUTICALS INC	$784.93M	96.50%	72.30%	21.48%	29.00%	0.23	1.94	91.40%	116.30%	33.02%
SPRO	SPERO THERAPEUTICS INC	$71.22M	35.60%	25.00%	28.95%	165.70%	0.12	10.50	100.00%	24.90%	25.33%
TAOX	TAO SYNERGIES INC	$27.05M	-134.10%	-109.50%	-83.05%	-152.70%	0.21	27.40	100.00%	-3,783.50%	-3,615.43%
RLMD	RELMADA THERAPEUTICS INC	$476.81M	-47.50%	-44.00%	-29.26%	-49.00%	0.06	29.52	N/A	N/A	N/A
CRMD	CORMEDIX INC	$572.70M	50.40%	27.40%	27.34%	86.10%	0.87	2.98	85.80%	45.20%	46.94%
TVTX	TRAVERE THERAPEUTICS INC	$5.68B	-55.80%	-7.00%	-5.16%	-5.00%	31.60	4.05	98.60%	-7.40%	-5.64%
UTHR	UNITED THERAPEUTICS CORP	$126.30B	20.20%	18.00%	23.97%	31.10%	0.13	5.73	86.10%	41.60%	50.25%
KRYS	KRYSTAL BIOTECH INC	$9.68B	19.30%	17.70%	16.50%	27.80%	0.10	8.32	94.60%	54.80%	51.45%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.76B	-4.50%	-1.70%	1.07%	1.10%	1.67	4.47	98.90%	-4.20%	2.20%
XLO	XILIO THERAPEUTICS INC	$54.92M	-117.20%	-21.40%	-25.97%	108.70%	1.25	3.59	100.00%	-58.50%	-58.52%
QTTB	Q32 BIO INC	$458.75M	76.90%	45.20%	30.58%	259.20%	0.09	20.30	100.00%	62.90%	62.87%
ARDX	ARDELYX INC	$981.80M	-36.00%	-10.80%	-7.52%	-5.80%	2.87	3.34	94.40%	-12.40%	-7.40%
XFOR	X4 PHARMACEUTICALS INC	$424.35M	-63.10%	-36.90%	-34.84%	-84.60%	0.63	11.30	81.50%	-568.80%	-513.82%
ADMA	ADMA BIOLOGICS INC	$2.22B	39.60%	26.60%	37.03%	38.00%	0.68	6.97	64.70%	33.00%	43.98%
RANI	RANI THERAPEUTICS HOLDINGS INC	$97.25M	-245.50%	-85.60%	-72.07%	-144.10%	0.58	3.40	100.00%	-929.10%	-864.78%
NRXS	NEURAXIS INC	$78.64M	-205.90%	-115.30%	-121.14%	604.80%	0.52	2.89	85.00%	-188.60%	-167.82%
INDP	INDAPTUS THERAPEUTICS INC	$134.76M	-1,028.80%	-299.70%	-1,511.20%	929.90%	0.75	2.34	N/A	N/A	N/A
ELOX	ELOXX PHARMACEUTICALS INC	$22.78M	N/A	N/A	N/A	N/A	-2.12	0.53	N/A	N/A	N/A
KZIA	KAZIA THERAPEUTICS LTD	$786.72M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
LGND	LIGAND PHARMACEUTICALS INC	$5.76B	20.10%	11.70%	11.41%	15.40%	1.26	31.18	95.40%	67.90%	84.03%
ZYME	ZYMEWORKS INC	$1.73B	-72.10%	-37.10%	-40.81%	-39.70%	3.94	6.32	100.00%	-404.00%	-384.43%
ENTA	ENANTA PHARMACEUTICALS INC	$393.14M	-64.00%	-20.20%	-19.19%	-18.40%	1.70	3.84	100.00%	-89.60%	-74.39%
AGEN	AGENUS INC	$307.49M	-38.00%	44.80%	-255.57%	236.40%	-1.90	0.34	99.50%	69.20%	113.88%
ALGS	ALIGOS THERAPEUTICS INC	$90.92M	-160.70%	-92.30%	-199.07%	-228.40%	1.08	2.19	100.00%	-241.00%	-239.91%
AXSM	AXSOME THERAPEUTICS INC	$11.30B	-255.60%	-27.00%	-61.82%	-127.70%	8.14	1.43	93.20%	-24.70%	-23.96%
ARVN	ARVINAS INC	$587.82M	1.90%	1.30%	1.70%	2.00%	0.20	7.91	97.20%	2.90%	3.19%
TTRX	TURN THERAPEUTICS INC	$304.43M	-117.30%	-38.90%	-28.39%	-304.20%	2.05	2.23	N/A	N/A	N/A
CBIO	CRESCENT BIOPHARMA INC	$619.93M	-99.10%	-86.90%	-99.33%	2,179.90%	0.12	9.66	100.00%	-1,522.70%	-1,504.28%
HYPD	HYPERION DEFI INC	$40.02M	-68.40%	-54.50%	-41.16%	-44.30%	0.20	1.97	70.90%	-3,402.70%	-2,588.52%
IFRX	INFLARX NV	$294.74M	-58.00%	-46.60%	-26.62%	-170.10%	0.14	8.22	48,201.60%	387,532.10%	386,807.32%
QNCX	QUINCE THERAPEUTICS INC	$26.68M	N/A	-38.10%	-197.19%	-215.70%	0.70	2.92	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$1.92B	-10.00%	-4.10%	-4.87%	-4.30%	1.09	4.42	59.10%	-6.90%	-6.63%
ANL	ADLAI NORTYE LTD	$522.68M	-414.00%	-67.20%	472.51%	547.00%	-5.14	0.65	100.00%	-710.60%	-679.94%
OKUR	ONKURE THERAPEUTICS INC	$165.63M	-49.00%	-45.80%	-33.99%	4,223.60%	0.04	26.75	N/A	N/A	N/A
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$1.63B	N/A	N/A	N/A	N/A	0.13	8.74	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$427.90M	-50.70%	-33.20%	-34.38%	-38.90%	0.40	9.01	100.00%	-297.80%	-297.41%
INVA	INNOVIVA INC	$1.50B	30.00%	21.60%	26.43%	39.20%	0.38	16.01	72.20%	81.20%	99.46%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

PBYI passed 14 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 80.82% over the past year, overperforming other biotech stocks by 88 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -31.58% from Puma Biotechnology's current stock price of $8.77.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 64.41% over the past year, overperforming other biotech stocks by 71 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the #3 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Corcept Therapeutics (NASDAQ:CORT) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Corcept Therapeutics (NASDAQ:CORT) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

CORT passed 17 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 55.43% over the past year, overperforming other biotech stocks by 62 percentage points.

Corcept Therapeutics has an average 1 year price target of $122.60, an upside of 9.6% from Corcept Therapeutics's current stock price of $111.86.

Corcept Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Corcept Therapeutics, 60% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 31.05%, which is 26 percentage points higher than the biotech industry average of 5.37%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.88%, which is 1 percentage points higher than the biotech industry average of 5.37%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.7%, which is -3 percentage points lower than the biotech industry average of 5.37%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.12% in the last day, and up 3.4% over the last week. Pds Biotechnology was the among the top losers in the biotechnology industry, dropping -64.84% yesterday.

PDS Biotechnology shares are trading lower after the company issued CEO letter outlining plans to advance PDS0301 and pursue partnerships for PDS0101 after ceasing internal investment in its Phase 3 study.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 14, which is 1 points higher than the biotech industry average of 13. It passed 1 out of 7 valuation due diligence checks.

Exelixis's stock has gained 37.21% in the past year. It has overperformed other stocks in the biotech industry by 44 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 13.56% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 57, which is 44 points higher than the biotech industry average of 13. It passed 4 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 123.91% in the past year. It has overperformed other stocks in the biotech industry by 131 percentage points.

Are biotech stocks a good buy now?

68.09% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 48.53% over the next year.

3.46% of biotech stocks have a Zen Rating of A (Strong Buy), 4.11% of biotech stocks are rated B (Buy), 41.77% are rated C (Hold), 38.96% are rated D (Sell), and 11.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.